Woodline Partners’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $15.3M | Hold |
|
|||||
|
2025
Q2 | $11.1M | Sell |
|
|||||
|
2025
Q1 | $14.7M | Buy |
|
|||||
|
2024
Q4 | $6.42M | Buy |
|
|||||
|
2024
Q3 | $15.4M | Buy |
|
|||||
|
2024
Q2 | $6.32M | Sell |
|
|||||
|
2024
Q1 | $11.5M | Sell |
|
|||||
|
2023
Q4 | $25.6M | Buy |
|
|||||
|
2023
Q3 | $15.1M | Sell |
|
|||||
|
2023
Q2 | $21M | Buy |
|
|||||
|
2023
Q1 | $10M | Sell |
|
|||||
|
2022
Q4 | $20.1M | Sell |
|
|||||
|
2022
Q3 | $28.3M | Buy |
|
|||||
|
2022
Q2 | $18.7M | Buy |
|
|||||
|
2022
Q1 | $20.6M | Buy |
|
|||||
|
2021
Q4 | $21.2M | Sell |
|
|||||
|
2021
Q3 | $27.5M | Buy |
|
|||||
|
2021
Q2 | $14M | Buy |
|
|||||
|
2021
Q1 | $9.24M | Buy |
|